ADVERTISEMENT
Aug. 23 -- ChemChina has won U.S. approval for its $43B takeover of Syngenta. That was seen as the biggest regulatory hurdle in the pursuit of this Swiss agrichemical and seed company. Bloomberg's Jonathan Browning reports on "Trending Business."
ADVERTISEMENT
RECOMMENDED FOR YOU
IPO Adda | Indegene Management On IPO Plans | NDTV Profit
IPO Adda | Aadhar Housing Finance MD & CEO Discusses Plans | NDTV Profit
NDTV Profit
IGX MD & CEO Rajesh Mediratta On New Small Scale LNG Contracts | NDTV Profit
NDTV Profit
TBO Tek To Launch Rs 1,550 Crore IPO | NDTV Profit
NDTV Profit
Indeed India's Sashi Kumar On Hiring Trends In India | NDTV Profit
NDTV Profit
Star Health's Q4 Report: Post-Hike Trends Discussed With Nilesh Kambli; Multiple Banking Partnerships
NDTV Profit
View All